Lite Strategy, Inc.
US ˙ NasdaqCM ˙ US55279B3015

Introduction

This page provides a comprehensive analysis of the known insider trading history of Thomas C Reynolds. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Thomas C Reynolds has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MEIP / MEI Pharma, Inc. Director 50,000
US:SGEN / Seagen Inc Chief Medical Officer 11,035
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Thomas C Reynolds. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases LITS / Lite Strategy, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in LITS / Lite Strategy, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2019-12-19 MEIP Reynolds Thomas C 10,000 1.6000 500 32.0000 16,000 187 1720 844,000 5,275.00

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LITS / Lite Strategy, Inc. Insider Trades
Insider Sales LITS / Lite Strategy, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in LITS / Lite Strategy, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

LITS / Lite Strategy, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Thomas C Reynolds as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-07-06 2021-07-01 4 MEIP MEI Pharma, Inc.
Stock Option (Right to Buy)
A - Award 50,000 50,000
2020-07-07 2020-07-02 4 MEIP MEI Pharma, Inc.
Stock Option (Right to Buy)
A - Award 50,000 50,000
2019-12-20 2019-12-19 4 MEIP MEI Pharma, Inc.
Common Stock
P - Purchase 10,000 10,000 1.60 16,000 16,000
2019-07-03 2019-07-01 4 MEIP MEI Pharma, Inc.
Stock Option (Right to Buy)
A - Award 40,000 40,000
2018-07-16 2018-07-12 4 MEIP MEI Pharma, Inc.
Stock Option (Right to Buy)
A - Award 40,000 40,000
2017-07-10 2017-07-06 4 MEIP MEI Pharma, Inc.
Option to purchase shares of common stock
A - Award 40,000 121,049 49.35
2016-08-01 2016-07-29 4 MEIP MEI Pharma, Inc.
Option to purchase shares of common stock
A - Award 40,000 81,049 97.44
2015-07-29 2015-07-28 4 MEIP MEI Pharma, Inc.
Option to purchase shares of common stock
A - Award 20,000 41,049 95.02
2014-07-16 2014-07-14 4 MEIP MEI Pharma, Inc.
Option to purchase shares of common stock
A - Award 8,000 21,049 61.31
2013-07-17 2013-07-15 4 MEIP MEI Pharma, Inc.
Options to purchase shares of common stock
A - Award 6,730 13,049 106.50
2013-02-11 2013-02-07 4 MEIP MEI Pharma, Inc.
Options to purchase shares of common stock
A - Award 6,319 6,319
2013-01-29 2013-01-28 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -1,576 11,035 -12.50
2013-01-29 2013-01-28 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -2,604 41,147 -5.95
2013-01-29 2013-01-28 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -1,027 7,196 -12.49
2013-01-29 2013-01-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2,604 57,601 -4.33 30.19 -78,609 1,738,847
2013-01-29 2013-01-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,604 60,205 4.52 12.00 31,248 722,460
2013-01-29 2013-01-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1,576 57,601 -2.66 30.19 -47,576 1,738,847
2013-01-29 2013-01-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 1,576 59,177 2.74 12.16 19,164 719,592
2013-01-29 2013-01-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -1,027 57,601 -1.75 30.19 -31,003 1,738,847
2013-01-29 2013-01-28 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 1,027 58,628 1.78 12.16 12,488 712,916
2013-01-29 2013-01-25 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -2,083 58,116 -3.46
2013-01-29 2013-01-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2,083 57,601 -3.49 29.84 -62,155 1,718,774
2013-01-29 2013-01-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,083 59,684 3.62 15.46 32,203 922,715
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -4,167 60,199 -6.47
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -33,643 12,611 -72.74
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -12,605 43,751 -22.37
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -35,493 0 -100.00
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -35,492 35,493 -50.00
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -3,679 0 -100.00
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -4,167 57,601 -6.75 28.01 -116,700 1,613,162
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 4,167 61,768 7.23 15.46 64,422 954,933
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -12,605 57,601 -17.95 28.01 -353,013 1,613,162
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 12,605 70,206 21.88 12.00 151,260 842,472
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -33,643 57,601 -36.87 28.01 -942,199 1,613,162
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 33,643 91,244 58.41 12.16 409,099 1,109,527
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -35,493 57,601 -38.13 28.00 -993,804 1,612,828
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 35,493 93,094 61.62 11.09 393,617 1,032,412
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -35,492 57,601 -38.13 28.00 -993,776 1,612,828
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 35,492 93,093 61.62 11.09 393,606 1,032,401
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -3,679 57,601 -6.00 28.01 -103,033 1,613,162
2013-01-17 2013-01-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3,679 61,280 6.39 11.09 40,800 679,595
2012-12-10 2012-12-10 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -1,250 0 -100.00
2012-12-10 2012-12-10 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -5,338 3,679 -59.20
2012-12-10 2012-12-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -5,338 57,601 -8.48 25.75 -137,454 1,483,226
2012-12-10 2012-12-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 5,338 62,939 9.27 11.09 59,198 697,994
2012-12-10 2012-12-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -1,250 57,601 -2.12 25.75 -32,188 1,483,226
2012-12-10 2012-12-10 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 1,250 58,851 2.17 10.29 12,862 605,577
2012-12-10 2012-12-07 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -30,000 1,250 -96.00
2012-12-10 2012-12-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -30,000 57,601 -34.25 25.77 -773,082 1,484,343
2012-12-10 2012-12-07 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 30,000 87,601 52.08 10.29 308,700 901,414
2012-12-10 2012-12-06 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -30,000 46,254 -39.34
2012-12-10 2012-12-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -30,000 57,601 -34.25 25.77 -772,983 1,484,153
2012-12-10 2012-12-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 30,000 87,601 52.08 12.16 364,800 1,065,228
2012-12-06 2012-12-05 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 76,254 -11.59
2012-12-06 2012-12-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 57,601 -14.79 25.60 -256,000 1,474,586
2012-12-06 2012-12-05 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 67,601 17.36 12.16 121,600 822,028
2012-12-06 2012-12-04 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 86,254 -10.39
2012-12-06 2012-12-04 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 86,254 -10.39
2012-12-06 2012-12-04 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 96,254 -9.41
2012-12-06 2012-12-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 57,601 -14.79 25.75 -257,500 1,483,226
2012-12-06 2012-12-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 67,601 17.36 12.00 120,000 811,212
2012-12-06 2012-12-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 57,601 -14.79 25.55 -255,500 1,471,706
2012-12-06 2012-12-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 67,601 17.36 12.16 121,600 822,028
2012-12-06 2012-12-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 67,601 17.36 12.16 121,600 822,028
2012-12-06 2012-12-04 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 57,601 -14.79 25.45 -254,500 1,465,945
2012-12-03 2012-12-03 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 106,254 -8.60
2012-12-03 2012-12-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 57,601 -14.79 25.45 -254,500 1,465,945
2012-12-03 2012-12-03 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 67,601 17.36 12.16 121,600 822,028
2012-12-03 2012-11-30 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -523 116,254 -0.45
2012-12-03 2012-11-30 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -9,477 66,356 -12.50
2012-12-03 2012-11-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -523 57,601 -0.90 25.50 -13,336 1,468,826
2012-12-03 2012-11-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 523 58,124 0.91 12.16 6,360 706,788
2012-12-03 2012-11-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -9,477 57,601 -14.13 25.50 -241,664 1,468,826
2012-12-03 2012-11-30 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 9,477 67,078 16.45 12.00 113,724 804,936
2012-12-03 2012-11-29 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -325 75,833 -0.43
2012-12-03 2012-11-29 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 76,158 -11.61
2012-12-03 2012-11-29 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -9,675 86,158 -10.10
2012-12-03 2012-11-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -325 57,601 -0.56 25.50 -8,288 1,468,826
2012-12-03 2012-11-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 325 57,926 0.56 12.00 3,900 695,112
2012-12-03 2012-11-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 57,601 -14.79 25.25 -252,500 1,454,425
2012-12-03 2012-11-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 67,601 17.36 12.00 120,000 811,212
2012-12-03 2012-11-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -9,675 57,601 -14.38 25.46 -246,297 1,466,354
2012-12-03 2012-11-29 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 9,675 67,276 16.80 12.00 116,100 807,312
2012-11-26 2012-11-26 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -3,000 95,833 -3.04
2012-11-26 2012-11-26 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -3,000 57,601 -4.95 25.50 -76,500 1,468,826
2012-11-26 2012-11-26 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 3,000 60,601 5.21 12.00 36,000 727,212
2012-11-26 2012-11-23 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 98,833 -9.19
2012-11-26 2012-11-23 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -7,000 108,833 -6.04
2012-11-26 2012-11-23 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 57,601 -14.79 25.26 -252,600 1,455,001
2012-11-26 2012-11-23 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 67,601 17.36 12.00 120,000 811,212
2012-11-26 2012-11-23 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -7,000 57,601 -10.84 25.50 -178,500 1,468,826
2012-11-26 2012-11-23 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 7,000 64,601 12.15 12.00 84,000 775,212
2012-11-26 2012-11-21 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 64,366 -13.45
2012-11-26 2012-11-21 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 57,601 -14.79 25.25 -252,500 1,454,425
2012-11-26 2012-11-21 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 67,601 17.36 15.46 154,600 1,045,111
2012-11-20 2012-11-20 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -9,166 74,366 -10.97
2012-11-20 2012-11-20 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -834 115,833 -0.71
2012-11-20 2012-11-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -834 57,601 -1.43 25.00 -20,850 1,440,025
2012-11-20 2012-11-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 834 58,435 1.45 12.00 10,008 701,220
2012-11-20 2012-11-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -9,166 57,601 -13.73 25.00 -229,150 1,440,025
2012-11-20 2012-11-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 9,166 66,767 15.91 15.46 141,706 1,032,218
2012-11-20 2012-11-19 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 83,532 -10.69
2012-11-20 2012-11-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale -10,000 57,601 -14.79 24.90 -249,002 1,434,276
2012-11-20 2012-11-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 10,000 67,601 17.36 15.46 154,600 1,045,111
2012-09-10 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
M - Exercise -48,540 0 -100.00
2012-09-10 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -48,540 57,601 -45.73 29.75 -1,444,065 1,713,630
2012-09-10 2012-09-06 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 48,540 106,141 84.27 8.24 399,970 874,602
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 61,169 61,169 26.10 1,596,511 1,596,511
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy)
A - Award 3,831 3,831 26.10 99,989 99,989
2012-08-22 2012-08-20 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 26,000 57,601 82.28
2012-05-17 2012-05-15 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -949 0 -100.00
2012-05-17 2012-05-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -949 31,073 -2.96 19.75 -18,743 613,692
2012-05-17 2012-05-15 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 949 32,022 3.05 8.24 7,820 263,861
2012-04-26 2012-04-25 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -40,000 949 -97.68
2012-04-26 2012-04-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -40,000 31,073 -56.28 19.75 -790,000 613,692
2012-04-26 2012-04-25 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 40,000 71,073 128.73 8.24 329,600 585,642
2012-03-23 2012-03-22 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -40,000 40,949 -49.41
2012-03-23 2012-03-22 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -40,000 31,073 -56.28 19.78 -791,100 614,546
2012-03-23 2012-03-22 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 40,000 71,073 128.73 8.24 329,600 585,642
2012-03-20 2012-03-19 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -37,700 80,949 -31.77
2012-03-20 2012-03-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -37,700 31,073 -54.82 19.75 -744,575 613,692
2012-03-20 2012-03-19 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 37,700 68,773 121.33 8.24 310,648 566,690
2012-03-20 2012-03-16 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -2,300 118,649 -1.90
2012-03-20 2012-03-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -2,300 31,073 -6.89 19.75 -45,425 613,692
2012-03-20 2012-03-16 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 2,300 33,373 7.40 8.24 18,952 274,994
2012-01-30 2012-01-27 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
M - Exercise -40,000 120,949 -24.85
2012-01-30 2012-01-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
S - Sale X -40,000 30,169 -57.01 19.75 -790,000 595,838
2012-01-30 2012-01-27 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
M - Exercise 40,000 70,169 132.59 8.24 329,600 578,193
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)